Thomas Luby is currently the Chief Innovation Officer at Texas Medical Center, a position held since 2025. They also serve on the Product Development Advisory Committee at the Cancer Prevention and Research Institute of Texas and have held various leadership roles in innovation and research ventures, including at Johnson & Johnson and Shire HGT. Additionally, Thomas is active on the boards of multiple organizations, including March Biosciences, Noninvasix, and Briteseed, LLC. They are pursuing a B.S. in Biology from the State University of New York College at Plattsburgh and a Ph.D. in Immunology from Tufts University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices